Expedeon’s proprietary immunoassay technology to be incorporated into Quanterix’ Simoa Planar Immunoassay products Heidelberg, Germany and Cambridge, UK – Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced a supply and license agreement with United States based Life Sciences company, Quanterix Corporation. The agreement provides Quanterix access to Expedeon’s breadth of immunoassay technologies for application […]
MANASSAS, Va. — Reinforcing its long-established reputation for quality and reliability as the steward for credible biomaterial and standards in the biological sciences, ATCC today announced details of its new initiative, Incredible 2020. Building on ATCC’s non-profit mission, this Incredible 2020 initiative, which was unveiled at the Society for Neuroscience (SfN) 2018 annual conference in San Diego, CA, […]
Today, Bioinformatics Solutions Inc. (BSI) will be releasing PEAKS X within its PEAKS Studio platform, to provide a complete and vendor neutral solution for DDA and DIA discovery proteomics. The latest features added to the software include: • Resolution for Chimeric Spectra • Spectral-Library-Free DIA Support • De Novo Sequencing for DIA Data • Improved […]
Los Angeles, CA – Calibre Scientific is pleased to announce that it has completed the acquisition of Kalon Biological Limited and Clin-Tech Limited (together “KalonBio“ or the “Company”). The Company specializes in the development and manufacture of a range of medical diagnostic kits, commercial ELISA (enzyme immunoassays [EIA]) kits and reagents for the healthcare and […]
Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that MacroGenics(NASDAQ:MGNX) and NanoString have entered into a translational research agreement to identify and develop biomarkers for MacroGenics’ MGD013 program. MGD013 is an IgG4κ bispecific […]
Melbourne, Australia and Cambridge, Massachusetts – October 25, 2018 | Leica Biosystems and Ultivue begin Co-Marketing of UltiMapper™ Assay on the BOND RX enabling single-step automated multiplexing in under 6 hours. Building on its legacy of partnering with emerging technology leaders, Leica Biosystems have partnered with Ultivue and announced the co-marketing of Ultivue’s UltiMapper™ assays […]
Bio-Works has received an order of 1,6 million SEK from PolyPeptide. In total, Bio-Works has received seven orders from PolyPeptide, four during 2017 and three during 2018. PolyPeptide is one of the largest contract manufacturers in the world for peptide pharmaceuticals. They control 25 % of the global market for contract manufacturing of peptide pharmaceuticals. […]
New premises at Milton Park, Oxfordshire, UK and in Boston, MA support rapid expansion of company Oxford, UK: Aigenpulse Ltd., (Aigenpulse), a company at the forefront of employing data technologies and advanced machine learning to accelerate drug discovery, today announced it has moved into larger premises at Milton Park, Oxfordshire, UK and opened offices […]
The companies will collaborate on the discovery of novel monospecific antibodies to develop bispecific therapeutics targeting cytokine-receptor pathways with applications in dermatology, inflammation, and autoimmunity by leveraging Zymeworks’ Azymetric™ and EFECT™ therapeutic platforms LEO Pharma will retain the rights to develop two bispecifics for dermatology applications; Zymeworks will retain the rights to develop antibodies from […]
Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection LEXINGTON, Mass.– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration agreement with OncoGenesis, a molecular protein-based cervical screening company, to develop a quantitative, protein biomarker diagnostic test for cervical health using […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
